Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments Podcast Por arte de portada

Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Quantum BioPharma is developing a portfolio of products including Quantum's Lucid-MS drug development and their drink, unbuzzd. In this episode, Adam Torres and Jason Sawyer, Head of Finance & M&A at Quantum BioPharma, explore Quantum BioPharma. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices
Todavía no hay opiniones